Skip to content

Annexon ANNX Total Current Assets

Total Current Assets at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$18.21B+3.6%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.12B+313%
Omeros logo
OmerosOMER
$180.36M+87.5%
Vor Biopharma logo
Vor BiopharmaVOR
$500.78M+672%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$361.41M+13.7%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$589.04M+156%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$843.79M+223%
Enterprise value$694.02M+261%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's total current assets?
Annexon (ANNX) reported total current assets of $228.27M in Q1 2026.
How has Annexon's total current assets changed year-over-year?
Annexon's total current assets decreased by 14.9% year-over-year, from $268.16M to $228.27M.
What is the long-term trend for Annexon's total current assets?
Over 5 years (2020 to 2025), Annexon's total current assets has grown at a -7.3% compound annual growth rate (CAGR), from $354.01M to $242.19M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.